| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |